全文获取类型
收费全文 | 1318227篇 |
免费 | 99980篇 |
国内免费 | 6064篇 |
专业分类
耳鼻咽喉 | 18609篇 |
儿科学 | 42655篇 |
妇产科学 | 38322篇 |
基础医学 | 190941篇 |
口腔科学 | 36207篇 |
临床医学 | 113533篇 |
内科学 | 255690篇 |
皮肤病学 | 26955篇 |
神经病学 | 100764篇 |
特种医学 | 51818篇 |
外国民族医学 | 386篇 |
外科学 | 201920篇 |
综合类 | 37764篇 |
现状与发展 | 11篇 |
一般理论 | 302篇 |
预防医学 | 96264篇 |
眼科学 | 30210篇 |
药学 | 103140篇 |
38篇 | |
中国医学 | 6467篇 |
肿瘤学 | 72275篇 |
出版年
2018年 | 13556篇 |
2017年 | 10624篇 |
2016年 | 11709篇 |
2015年 | 14113篇 |
2014年 | 18867篇 |
2013年 | 27126篇 |
2012年 | 37057篇 |
2011年 | 39770篇 |
2010年 | 23897篇 |
2009年 | 22101篇 |
2008年 | 37354篇 |
2007年 | 40693篇 |
2006年 | 41110篇 |
2005年 | 40046篇 |
2004年 | 38868篇 |
2003年 | 38385篇 |
2002年 | 37618篇 |
2001年 | 60201篇 |
2000年 | 60822篇 |
1999年 | 51323篇 |
1998年 | 14102篇 |
1997年 | 12608篇 |
1996年 | 12663篇 |
1995年 | 12625篇 |
1994年 | 12007篇 |
1993年 | 10987篇 |
1992年 | 41112篇 |
1991年 | 40500篇 |
1990年 | 40008篇 |
1989年 | 38807篇 |
1988年 | 36173篇 |
1987年 | 35409篇 |
1986年 | 33759篇 |
1985年 | 32183篇 |
1984年 | 23917篇 |
1983年 | 20797篇 |
1982年 | 12325篇 |
1981年 | 10889篇 |
1979年 | 22605篇 |
1978年 | 15832篇 |
1977年 | 13684篇 |
1976年 | 12932篇 |
1975年 | 14165篇 |
1974年 | 16659篇 |
1973年 | 16042篇 |
1972年 | 15306篇 |
1971年 | 14222篇 |
1970年 | 13202篇 |
1969年 | 12720篇 |
1968年 | 11969篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
3.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
4.
目的:基于以价值为基础的定价方法,计算核医学学科新增医疗服务项目镭[223 Ra]骨转移瘤治疗的医疗服务价格。为相关新增医疗服务项目的申报和定价打下循证基础,为合理补偿医务人员劳动价值、提升患者服务项目可及性提供依据。方法:采集2021年3—12月使用“镭核素[223 Ra]骨转移瘤治疗资源投入及费用数据采集表”相关数据,开展专家访谈进行系数赋值和基线对照项目确定,得到镭[223 Ra]骨转移瘤治疗服务各个环节的成本和新增服务的价值。结果:镭[223 Ra]骨转移瘤治疗服务按服务特点分为注射前评估、治疗计划、给药、给药后监测、废弃物处理与监测等环节,各环节3地平均人力耗时分别为104分钟、39分钟、25分钟、72分钟和56分钟,中位物耗成本为48.20元,3地总成本(平均人力成本+中位物耗成本)为763.68元。结合系数赋值结果和基线对比项目,得到新增项目的价值为810.19元。结论:运用基于技术难度和风险程度的价值定价理论,计算镭[223 Ra]骨转移瘤治疗新增医疗服务项目的服务价值,建议以价值作为服务定价依据。该定价公式和研究方法不仅可用于其他核医学学科新增服务项目的定价,还适用于现行医疗服务项目的价格动态调整,为未来学科价格工作提供方法学参考。 相似文献
5.
Jones type fifth metatarsal fractures pose a challenge to the foot and ankle surgeon, given documented high nonunion rates as well as high complication rates including hardware prominence, nerve injury, and screw breakage for existing treatment modalities including screw and plantar plate fixation. We call for the design of innovative Jones-fracture specific implants which contour to the natural curve of the fifth metatarsal. Future research should aim to expand upon existing literature for Jones fracture fixation and evaluate efficacy of novel implants which are designed to address unacceptably high complication rates for existing treatment modalities. 相似文献
6.
Qing-Yang Que Lin-Cheng Zhang Jia-Qi Bao Sun-Bin Ling Xiao Xu 《World journal of gastrointestinal surgery》2022,14(5):397-408
Over the last 40 years, the incidence and prevalence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have continued to increase. Compared to other epithelial neoplasms in the same organ, GEP-NENs exhibit indolent biological behavior, resulting in more chances to undergo surgery. However, the role of surgery in high-grade or advanced GEP-NENs is still controversial. Surgery is associated with survival improvement of well-differentiated high-grade GEP-NENs, whereas poorly differentiated GEP-NENs that may benefit from resection require careful selection based on Ki67 and other tissue bio markers. Additionally, surgery also plays an important role in locally advanced and metastatic disease. For locally advanced GEP-NENs, isolated major vascular involvement is no longer an absolute contraindication. In the setting of metastatic GEP-NENs, radical intended surgery is recommended for patients with low-grade and resectable metastases. For unresectable metastatic disease, a variety of surgical approaches, including cytoreduction of liver metastasis, liver transplantation, and surgery after neoadjuvant treatment, show survival benefits. Primary tumor resection in GEP-NENs with unresectable metastatic disease is associated with symptom control, prolonged survival, and improved sensitivity toward systemic therapies. Although there is no established neoadjuvant or adjuvant strategy, increasing attention has been given to this emerging research area. Some studies have reported that neoadjuvant therapy effectively reduces tumor burden, improves the effectiveness of subsequent surgery, and decreases surgical complications. 相似文献
7.
目的分析维生素D3辅助治疗哮喘合并呼吸道感染对气道重塑及免疫功能的影响。 方法选取我院2020年1月至2021年1月收治的56例哮喘患者为对象,随机分为两组,其中采取常规治疗为对照组24例,采用维生素D3辅助治疗为观察组32例。比较两组临床疗效,咳嗽、咳痰、气喘、胸闷以及肺内哮鸣声消失时间,T细胞亚群变化以及气道重塑指标变化,比较不良反应发生情况。 结果观察组临床治疗总有效率显著高于对照组,同时咳嗽、咳痰、气喘、胸闷以及肺哮鸣音等消失时间明显好于对照组(P<0.05);观察组CD4+、CD4+/CD8+显著高于对照组(P<0.05);观察组高于对照组(P<0.05)。两组不良反应率差异(P>0.05)。 结论使用维生素D3辅助治疗哮喘合并呼吸道感染可增强患者的免疫功能,延缓气道重塑纤维化进程,安全性高。 相似文献
8.
9.